Clinical Trial Update: Study on the Safety and Efficacy of RAG-21 in the Treatment of Amyotrophic Lateral Sclerosis Patients With FUS Gene Mutations [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 clinical trial update reports evaluating the safety and potential efficacy of RAG-21 for amyotrophic lateral sclerosis in patients with FUS gen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• RAG-21

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Amyotrophic Lateral Sclerosis (ALS) | EARLY_Phase 1 | Status: NOT_YET_RECRUITING